Bone marrow produces sufficient alloreactive natural killer (NK) cells in vivo to cure mice from subcutaneously and intravascularly injected 4T1 breast cancer

PURPOSE: Administration of 5 million alloreactive natural killer (NK) cells after low-dose chemo-irradiation cured mice of 4T1 breast cancer, supposedly dose dependent. We now explored the efficacy of bone marrow as alternative in vivo source of NK cells for anti-breast cancer treatment, as methods...

Descripción completa

Detalles Bibliográficos
Autores principales: van Gelder, Michel, Vanclée, Ariane, van Elssen, Catharina H. M. J., Hupperets, Pierre, Wieten, Lotte, Bos, Gerard M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Preclinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241334/
https://www.ncbi.nlm.nih.gov/pubmed/27915436
http://dx.doi.org/10.1007/s10549-016-4067-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241334/
https://www.ncbi.nlm.nih.gov/pubmed/27915436
http://dx.doi.org/10.1007/s10549-016-4067-6

Ejemplares similares